Phase 1 Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma.
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2012
At a glance
- Drugs Gimeracil/oteracil/tegafur; Sorafenib
- Indications Liver cancer
- Focus Adverse reactions
- 01 Feb 2012 Actual end date (Sep 2011) added as reported by ClinicalTrials.gov.
- 01 Feb 2012 Actual patients number is 20 as reported by ClinicalTrials.gov.
- 01 Feb 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.